INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,927,900 | -5.4% | 2,179,883 | +22.0% | 0.02% | 0.0% |
| Q2 2023 | $72,879,080 | +55.3% | 1,787,128 | +41.9% | 0.02% | +50.0% |
| Q1 2023 | $46,927,178 | +0.9% | 1,259,114 | -5.5% | 0.01% | -9.1% |
| Q4 2022 | $46,511,336 | +11.8% | 1,333,085 | +79.3% | 0.01% | +22.2% |
| Q3 2022 | $41,608,000 | +33.7% | 743,534 | +23.6% | 0.01% | +12.5% |
| Q2 2022 | $31,130,000 | -32.6% | 601,438 | -5.4% | 0.01% | -11.1% |
| Q1 2022 | $46,199,000 | +4.9% | 635,733 | +70.7% | 0.01% | 0.0% |
| Q4 2021 | $44,026,000 | -9.6% | 372,342 | +2.6% | 0.01% | -10.0% |
| Q3 2021 | $48,698,000 | -58.0% | 363,006 | -49.3% | 0.01% | -61.5% |
| Q2 2021 | $115,863,000 | +65.4% | 715,597 | -18.0% | 0.03% | +52.9% |
| Q1 2021 | $70,071,000 | -0.4% | 873,103 | -32.5% | 0.02% | -5.6% |
| Q4 2020 | $70,340,000 | +287.2% | 1,292,999 | +41.5% | 0.02% | +260.0% |
| Q3 2020 | $18,166,000 | +3.5% | 913,786 | +9.4% | 0.01% | -16.7% |
| Q2 2020 | $17,550,000 | +48.5% | 834,927 | -13.6% | 0.01% | +20.0% |
| Q1 2020 | $11,815,000 | +6.9% | 966,037 | +28.2% | 0.01% | +25.0% |
| Q4 2019 | $11,056,000 | +318.9% | 753,676 | +281.2% | 0.00% | +100.0% |
| Q3 2019 | $2,639,000 | -20.2% | 197,689 | -2.1% | 0.00% | +100.0% |
| Q2 2019 | $3,306,000 | +31.2% | 201,943 | +36.9% | 0.00% | 0.0% |
| Q1 2019 | $2,519,000 | +100.4% | 147,504 | +60.1% | 0.00% | – |
| Q4 2018 | $1,257,000 | -55.4% | 92,145 | -6.5% | 0.00% | -100.0% |
| Q3 2018 | $2,820,000 | +55.9% | 98,552 | +49.1% | 0.00% | 0.0% |
| Q2 2018 | $1,809,000 | -40.6% | 66,100 | -54.2% | 0.00% | -50.0% |
| Q1 2018 | $3,044,000 | +98.8% | 144,316 | +81.2% | 0.00% | – |
| Q4 2017 | $1,531,000 | +26.2% | 79,640 | +63.2% | 0.00% | – |
| Q3 2017 | $1,213,000 | – | 48,810 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |